読み込み中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新データ
$8.84
+$0.40 · +4.74%
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
前日終値
$8.84
+$0.40 · +4.74%
日中の時刻はETです。市場データは遅延する場合があります。
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
日中レンジ
現在 $8.84
52週レンジ
現在 $8.84
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
62
割安
センチメント
52
まちまち
リスク
53
やや高いリスク
モメンタム
68
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
日中レンジ
現在 $8.84
52週レンジ
現在 $8.84
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 4052万 USD | 3774.5万 USD | 3668.4万 USD | 4142万 USD | 3689.3万 USD |
| 売上原価 | 2707.9万 USD | 3051.4万 USD | 2638.8万 USD | 2394.4万 USD | 1927.2万 USD |
| 粗利益 | 1344.1万 USD | 723.1万 USD | 1029.6万 USD | 1747.6万 USD | 1762.1万 USD |
| 研究開発 | 219.7万 USD | 275.9万 USD | 556.7万 USD | 773.7万 USD | 431.2万 USD |
| 販売・一般管理 | 2707.2万 USD | 2947万 USD | 3478万 USD | 3744.9万 USD | 2416.9万 USD |
| 営業費用 | 3041.7万 USD | 3337.7万 USD | 4585.9万 USD | 6713.5万 USD | 2962.9万 USD |
| 受取利息 | — | — | — | 21.3万 USD | — |
| 支払利息 | 71万 USD | 68.7万 USD | 83.3万 USD | — | 58.9万 USD |
| 減価償却費と償却費 | 634.2万 USD | 657.8万 USD | 566万 USD | 316.5万 USD | 288.3万 USD |
| 営業利益 | −1697.6万 USD | −2614.6万 USD | −3556.3万 USD | −4965.9万 USD | −1200.8万 USD |
| 純利益 | −1725.9万 USD | −2674.5万 USD | −3678万 USD | −4746.8万 USD | −980.3万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$8.00
下落余地（9.50%）評価サンプルは3件と限定的です
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI1060.74万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM263.73万0.00%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF87.39万0.00%954億 USD0.05%$235+0.80%
iShares Biotechnology ETFIBB71.49万0.01%108.2億 USD0.44%$206.49+3.00%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM52万0.44%1.17億 USD0.73%$15.9402+0.25%
Vanguard Russell 2000 ETFVTWO46.88万0.00%180億 USD0.06%$112.66+0.50%
Avantis U.S. Small Cap Equity ETFAVSC31.01万0.01%30.82億 USD0.25%$69.98+0.03%
iShares Micro-Cap ETFIWC30.17万0.02%13.17億 USD0.60%$183+0.11%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Biotechnology ETFIBBEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMVanguard Russell 2000 ETFVTWOAvantis U.S. Small Cap Equity ETFAVSCiShares Micro-Cap ETFIWCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
